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Toward a Better Understanding of...
The Effect of  KATP Channel Mutations 
on Inhibitor Sensitivity: 
Implications for Personalized Treatment 
of Cantu Syndrome
David Tyus
Mentor: Conor McClenaghan
Cantu Syndrome (CS) is a rare, complex disease characterized by a wide array of 
cardiovascular features caused by mutations resulting in the overactivity of ATP-sensitive 
potassium (KATP) channels. KATP channels are heteromeric complexes composed of pore-
forming Kir6.x and regulatory SURx subunits. Currently, no cure exists for CS, but KATP 
inhibitors are promising candidates for the treatment of the disease; however, the effect 
of CS mutations on drug sensitivity have yet to be established. The goal of this project 
was to test a range of inhibitors against KATP channel mutations found in CS patients 
(Kir 6.1[V65M] and Kir 6.1[C176S]) to investigate their potential clinical benefit.  KATP 
activity in the presence or absence of inhibitors (glibenclamide, repaglinide [both SURx 
interacting], and terfenadine [Kir6.x interacting]) was determined by measuring the 
efflux of radioactive 86Rb+ from CosM6 cells transfected with wild type or mutated 
channels. These results show that these mutations resulted in decreased sensitivity to 
inhibitors of diverse structural classes which bind to different channel subunits. These 
findings demonstrate the need for comprehensive studies to investigate the effects of 
CS mutations on inhibitor sensitivity. Furthermore, these results predict poor clinical 
outcomes of certain KATP inhibitors for CS patients, which highlights the requirement for 
the development of novel inhibitors with new mechanisms of action.
